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Kru¨ppel-like factors (KLFs) recognize CACCC and GC-rich sequences in gene regulatory elements. Here, we
describe the disruption of the murine basic Kru¨ppel-like factor gene (Bklf or Klf3). Klf3 knockout mice have less
white adipose tissue, and their fat pads contain smaller and fewer cells. Adipocyte differentiation is altered in
murine embryonic fibroblasts from Klf3 knockouts. Klf3 expression was studied in the 3T3-L1 cellular system.
Adipocyte differentiation is accompanied by a decline in Klf3 expression, and forced overexpression of Klf3
blocks 3T3-L1 differentiation. Klf3 represses transcription by recruiting C-terminal binding protein (CtBP)
corepressors. CtBPs bind NADH and may function as metabolic sensors. A Klf3 mutant that does not bind
CtBP cannot block adipogenesis. Other KLFs, Klf2, Klf5, and Klf15, also regulate adipogenesis, and functional
CACCC elements occur in key adipogenic genes, including in the C/ebp promoter. We find that C/ebp is
derepressed in Klf3 and Ctbp knockout fibroblasts and adipocytes from Klf3 knockout mice. Chromatin
immunoprecipitations confirm that Klf3 binds the C/ebp promoter in vivo. These results implicate Klf3 and
CtBP in controlling adipogenesis.
Mammalian Kru¨ppel-like factor (KLF) proteins contain
three characteristic classical zinc fingers near their C termini
(29). These domains recognize CACCC and related GC-rich
elements in promoters and enhancers. Although the DNA-
binding domains of the KLF family proteins share similar func-
tions, their N-terminal domains are highly variable and display
different molecular functions, with some operating primarily in
gene activation and others in the repression of transcription.
Several members of the family are abundant in many (and
possibly all) tissues, while other KLFs are restricted in their
expression. In addition to detailed analysis of expression pro-
files, gene knockout experiments in mice have been useful in
defining the major biological roles of different family members.
For instance, Klf1 (also known as erythroid Kru¨ppel-like factor
gene [Eklf]) is highly expressed in erythroid tissues, and knock-
out experiments have demonstrated that it is required for de-
finitive erythropoiesis (4, 20, 25). Klf1 knockout embryos die in
utero around embryonic day 14.5 (E14.5) from failure to fully
activate the adult -globin gene. Chromatin immunoprecipita-
tion experiments and rescue experiments in Klf1 knockout cell
lines have confirmed that Klf1 binds to a CACCC box in the
-globin gene promoter and drives adult globin expression (8).
The biological roles of many of the other KLF proteins have
similarly been defined. KLFs are important in numerous cel-
lular processes, including the control of proliferation, differ-
entiation, and apoptosis, and different family members con-
tribute to the development of different tissues (5, 13, 29).
Recently, a combination of cellular and knockout experiments
has revealed that several family members contribute to adipo-
genesis. Klf2 is expressed early in adipogenesis, and later its
expression decreases (2, 35). Accordingly, using the well-char-
acterized 3T3-L1 cell model system, Klf2 has been shown to be
an inhibitor of adipogenesis. It has been proposed that it in-
hibits the activation of the peroxisome proliferator-activated
receptor  (PPAR) gene (PPAR); PPAR is a transcription
factor known to drive adipogenesis (2). In contrast, Klf5 ap-
pears to drive adipogenesis. It is expressed early during differ-
entiation, with maximal levels observed at 3 h after the onset of
3T3-L1 differentiation (21). Homozygous Klf5 knockout em-
bryos die early in gestation, but heterozygous animals survive
and show a deficiency in white adipose tissue (21). Further-
more, Klf5/ murine embryonic fibroblasts (MEFs) are im-
paired in their ability to differentiate into adipocytes (21).
Overexpression of Klf5 in 3T3-L1 cells enhances adipogenesis,
whereas a dominant-negative form blocks differentiation (21).
It has been proposed that Klf5 activates expression of the
PPAR gene (21). Klf15 is another positive regulator of adi-
pogenesis. Klf15 expression increases dramatically during
3T3-L1 differentiation (19), and overexpression in 3T3-L1 cells
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results in enhanced adipocyte formation (2). Ectopic expres-
sion of Klf15 in NIH 3T3 or C2C12 cells can direct these
nonadipocyte cell lines down the adipocyte lineage (19). This
effect is mediated by PPAR indicating that Klf15 acts up-
stream of PPAR in adipocyte differentiation (19). Other
KLFs, such as Klf6, Klf7, and possibly Klf11, have also been
implicated in adipogenesis and metabolic control (6, 14, 17).
The demonstration that various KLFs are instrumental in reg-
ulating adipocyte differentiation is consistent with the fact that
functional CACCC binding sites are found in the control re-
gions of key adipogenic genes, such as C/ebp (12, 30) and
Ppar (2, 19, 21).
We have been investigating another member of the KLF
family, basic Kru¨ppel-like factor (Klf3). Klf3 is primarily a
repressor of transcription. It contains an N-terminal repression
domain that includes a Pro-X-Asp-Leu-Ser motif that recruits
the well-characterized corepressor C-terminal binding protein
(CtBP) (32). CtBP binds and is activated by NADH. Accord-
ingly, it is viewed as a “metabolic sensor” that responds to the
redox state of the cell (36). The Klf3 gene is broadly expressed
(10) but its physiological roles have not been defined. In order
to identify biological processes that are dependent on Klf3, we
have disrupted the Klf3 gene by homologous recombination in
murine embryonic stem cells and generated Klf3-deficient
mice.
Klf3 knockout mice are smaller than their wild-type litter-
mates, but while most organs are proportionally smaller, there
is a marked reduction in white adipose tissue. Analysis of the
fat pads of the knockout animals shows that they contain
smaller and fewer cells. In order to determine whether there is
a defect in adipogenesis in these mice, MEFs from the knock-
out embryos were studied. These cells showed an increased
propensity to differentiate into lipid-forming cells in culture.
The molecular role of Klf3 was investigated using the 3T3-L1
system. It was found that Klf3 mRNA and protein levels were
high initially but declined as adipogenesis ensued. Forced ex-
pression of Klf3, but not of a Klf3 mutant unable to bind the
corepressor CtBP, blocked adipogenesis. This result implicates
CtBP in adipogenesis.
Microarray analyses have previously suggested that CtBP
may be involved in repressing C/ebp (11). We confirmed the
derepression of C/ebp in CtBP-deficient murine embryonic
fibroblasts and examined C/ebp levels in Klf3 knockout adi-
pocytes and in Klf3-deficient murine embryonic fibroblasts. In
all cases, C/ebp was found to be derepressed. Finally, chro-
matin immunoprecipitation experiments on undifferentiated
3T3-L1 cells (where Klf3 is abundant) show that Klf3 is asso-
ciated with the C/ebp promoter in vivo. We conclude that Klf3
and CtBP play a role in normal adipogenesis, at least in part
through the repression of key target genes, such as C/ebp.
MATERIALS AND METHODS
Generation of knockout mice. Klf3/ mice were generated by standard meth-
ods. Details of constructs are available on request. Experiments were performed
on mice maintained on the FVB/NJ background. All mice were housed at a
temperature of 24 to 28°C with a 12-h light-dark cycle and free access to water
and standard chow. Male and female mice were caged separately unless they
were used specifically for breeding purposes. Mice were weaned at 3 weeks of
age, and tail snips were taken for genomic DNA isolation. Ethical approval for
the use of animals used in this project was obtained from the Animal Care and
Ethics Committee (Sydney University; approval no. L02/1-2005/3/4048).
Genotyping. Genomic DNA was isolated from tail biopsies of 3-week-old mice
anesthetized with isoflurane (VCA I.S.O.; Veterinary Companies of Australia
Pty Ltd., Kings Park, NSW, Australia). For embryos, a small portion of the head
was used. Each tissue sample was digested overnight at 55°C in 350 l of DNA
lysis solution (50 mM Tris [pH 8.0], 100 mM EDTA, 100 mM NaCl, and 1%
[wt/vol] sodium dodecyl sulfate) plus 35 l of proteinase K (10 mg/ml). Following
protein digestion, 2 l of RNase A (5 mg/ml) was added, and samples were
incubated at 37°C for 30 min. DNA was extracted by adding 250 l of phenol-
chloroform-isoamyl alcohol (Progen Industries, Darra, QLD, Australia), with
vigorous shaking for 2 min at room temperature. The phases were separated by
centrifugation at 13,000  g for 2 min, and the aqueous phase was extracted with
250 l of chloroform, with vigorous shaking for 2 min at room temperature.
Phases were separated as above, and the DNA was precipitated from the aque-
ous phase by adding 250 l of isopropanol. Samples were vortexed and centri-
fuged at 13,000  g for 15 min at 4°C. DNA pellets were air dried for 30 min at
room temperature and then resuspended in 250 l of embryo transfer water
(Sigma Chemical Company, St. Louis, MO) at 4°C overnight.
Mice were genotyped using a single PCR to simultaneously identify neo and
Klf3 sequences. The sequences of forward and reverse primers used are as
follows: neo, 5-TGATGCAATGCGGCGGCTGCATAC-3 (forward) and 5-C
AGAAGAACTCGTCAAGAAGGCGA-3 (reverse); Klf3, 5-AAATGCACCT
GGGAAGGCTGCAC-3 (forward) and 5-CAGACTAGCATGTGGCGTTTC
CTG-3 (reverse).
The PCR was carried out in a 25-l solution containing 1 l of genomic DNA,
2.5 l of 10 REDTaq buffer, 1 l of 10 mM deoxynucleoside triphosphate
mixture (2.5 mM each), 0.2 l of each 100 M primer, and 1.25 units of REDTaq
DNA polymerase (Sigma). The thermal parameters of the PCR were 94°C for 2
min and 30 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 60 s, followed by
one final cycle of 72°C for 5 min.
Organ weight analysis. Twelve-week-old mice were weighed and then sacri-
ficed with a lethal injection of Euthanasia Fort Solution (Apex Laboratories Pty.
Ltd., Somersby, NSW, Australia). Various organs were immediately collected
and weighed.
Histological analysis of tissues. Four-day-old mice or fresh epididymal pads
from 12-week-old male mice were collected and fixed in 4% neutral buffered
formaldehyde solution. Hematoxylin-eosin (H-E) staining was performed at the
Histopathology Laboratory (Department of Pathology, Blackburn Building, Uni-
versity of Sydney).
Adipocyte size determination. Isolated adipocytes were obtained from excised
epididymal fat pads of 4-month-old mice by collagenase as previously described
(27). Cells were then fixed with 2% OsO4 in phosphate-buffered saline overnight
at 37°C. The adipocyte diameter of 800 to 1,500 cells was determined using
Photoshop software (Adobe Systems Inc.) from images of adipocyte suspensions
obtained by light microscopy. Since adipocytes have 95% lipid content and are
spherical in shape, cell volumes were estimated from the diameter.
Total DNA content from adipose tissue. Epididymal white adipose tissue was
dissected from 12-week-old mice and immediately frozen in liquid nitrogen.
Approximately 100 mg of tissue was homogenized using a PRO 200 homogenizer
(PROScientific Inc., Oxford, CT), and genomic DNA was extracted using TRI
reagent (Sigma) as described by the manufacturer. DNA per mg of tissue was
measured by UV spectrophotometry, and the total DNA content from fat pads
was determined by multiplying the obtained DNA concentration for each sample
by the average epididymal white adipose tissue weight for each genotype.
Cell culture, induction of adipocyte differentiation, and Oil Red O staining.
3T3-L1 cells were cultured at 37°C and 5% CO2 in high-glucose Dulbecco’s
modified Eagle’s medium (HG-DMEM) supplemented with 10% (vol/vol) heat
inactivated fetal calf serum (FCS) and 1% (vol/vol) penicillin, streptomycin, and
glutamine (PSG). Two days after the cells reached confluence, adipocyte differ-
entiation was induced (designated day 0). The medium was replaced with dif-
ferentiation medium (HG-DMEM, 10% FCS, 1% PSG, 2 g/ml insulin, 1 M
dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine). On day 3 postinduction
the medium was changed to postdifferentiation medium (HG-DMEM, 10% FCS,
1% PSG, 2 g/ml insulin). On day 6 and thereafter, the cells were maintained in
standard medium, which was replenished every 3 to 4 days.
MEFs were prepared from E14.5 Klf3/ embryos or their wild-type litter-
mates. The outgrowing primary cell population was passaged every 2 to 3 days
upon confluence and continuously cultured in HG-DMEM supplemented with
10% FCS and 1% PSG. MEFs were induced to differentiate as described above
for 3T3-L1 cells.
We are grateful to Jeffrey Hildebrand (University of Pittsburgh, Pittsburgh,
PA) for the gift of the Ctbp/ and Ctbp/ MEFs. These were cultured in the
same medium as described above for 3T3-L1 cells.
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EcoPack 2-293 packaging cells (Clontech, Mountain View, CA) were grown in
the same medium as described above for 3T3-L1 cells.
Oil Red O staining of differentiated cells was performed to visualize intracel-
lular lipid droplets. Cells were fixed in 4% neutral buffered formaldehyde for 30
min at room temperature. Cells were then rinsed quickly in water, followed by
60% isopropanol for 5 min. Oil Red O (Sigma) (0.3% in isopropanol) was
diluted with water (3:2), filtered, and then used to stain the cells for 5 min at
room temperature. Cells were washed with water. Where indicated, cells were
counterstained with hematoxylin for 1 min and washed for a final time with
water. The stained cells were visualized by light microscopy.
Real-time RT-PCR. RNA was isolated from 3T3-L1 cells at the indicated times
(see Fig. 5A), white adipose tissue of 12-week-old mice, and Klf3 and Ctbp
MEFs. RNA extraction, cDNA synthesis and real-time reverse transcription-
PCR (RT-PCR) were performed as previously described (10). The sequences of
forward and reverse primers used are as follows: Klf3, 5-TACAGGAGAAAA
GCCGTACAAATG-3 and 5-TCATCAGACCGAGCGAACTTC-3; C/ebp,
5-GAGCCGAGATAAAGCCAAACA-3 and 5-CGGTCATTGTCACTGGT
CAACT-3; C/ebp, 5-CAAGCTGAGCGACGAGTACA-3 and 5-CAGCTG
CTCCACCTTCTTCT-3; C/ebp	, 5-CGCAGACAGTGGTGAGCTTG-3 and
5-CTTGCGCACAGCGATGTTGTT-3; Ppar, 5-CTTGCTGTGGGGATGT
CTCACAA-3 and 5-GATCTCCGCCAACAGCTTCTCCT-3; Klf15, 5-TAC
ACCAAGAGCAGCCACCT-3 and 5-AACTCATCTGAGCGGGAAAA-3;
Klf2, 5-ACCAAGAGCTCGCACCTAAA-3 and 5-TCCTTCCCAGTTGCAA
TGAT-3; Klf5, 5-CCGGAGACGATCTGAAACAC-3 and 5-GGAGCTGAG
GGGTCAGATACTT-3; 18S, 5-CACGGCCGGTACAGTGAAAC-3 and 5-
AGAGGAGCGAGCGACCAA-3; Pgm2, 5-GGAGCAGGGATTTCTCGAA
TGAA-3 and 5-GGTCACTGAACTGCTTTTCCAGGT-3; Tbc1d1, 5-AATG
TGGTTCAGCCCACAGACAT-3 and 5-CCAGTGCAATCTTTTTGGTGTC
A-3; Tlr1, 5-TTCAAGTGTGCAGCTGATTGCTC-3 and 5-CAGTGCTAA
CGTGCCGAAGAGAT-3; Tlr6, 5-TAAGGAATTTGGCAACCTGACGA-3
and 5-CAAGTGAGCAACTGGGAGCAGAT-3.
Nuclear extract preparation and EMSAs. Nuclear extracts were prepared
from 3T3-L1 preadipocytes and adipocytes, and electrophoretic mobility shift
assays (EMSAs) were carried out as described previously (9). Generation of the
anti-Klf3 antibody has been described previously (9). The oligonucleotides used
in the synthesis of radiolabeled probes were from the mouse -major globin
promoter: 5-TAGAGCCACACCCTGGTAAG-3 and 5-CTTACCAGGGTG
TGGCTCTA-3.
Western blot analysis. The Western blot procedure was carried out as previ-
ously described (24). Briefly, nuclear extracts from 3T3-L1 preadipocytes and
adipocytes were separated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis, electrotransferred to nitrocellulose membrane, and analyzed with
antibodies against Klf3 as previously described (9) and -actin (Sigma). Detec-
tion was carried out using Western Lightning Chemiluminescence Reagent Plus
(Perkin Elmer Life Sciences, Boston, MA) and X-ray film (Eastman Kodak
Company, Rochester, NY).
Retroviral vectors. Full-length Klf3 and Klf3
DL (in which the DL residues in
the PXDLS motif are mutated [see below]) sequences were excised from pMT2-
Klf3 and pcDNA3-Klf3
DL and inserted into the BamHI and EcoRI sites of a
pMXs vector containing a puromycin resistance gene (generously supplied by
Toshio Kitamura, University of Tokyo, Tokyo, Japan) to generate the retroviral
vectors pMXs-Klf3 and pMXs-Klf3
DL.
Retroviral infection. To generate retrovirus, EcoPack 2-293 packaging cells
were transfected with 5 g of pMXs-Klf3, pMXs-Klf3
DL, or empty pMXs with
the use of FuGENE 6 (Roche Applied Science, Indianapolis, IN). After 8 h, the
cells were incubated in fresh medium. At 48 h after transfection, the supernatant
containing viral particles was harvested and passed through a filter (pore size,
0.45 m). 3T3-L1 cells were plated at a cell density of 1.5 105 cells/60-mm plate
12 h before infection. These cells were then incubated with the viral supernatants
in the presence of 8 g/ml Polybrene (Sigma) for 24 h. Cells successfully trans-
duced were selected on the basis of their resistance to puromycin (2.5 g/ml).
Differentiation of the stable transformants was then performed as described
above, and cells were stained with Oil Red O at day 5 of differentiation.
ChIP assays. Approximately 5  106 3T3-L1 cells were used for each chro-
matin immunoprecipitation (ChIP). Cross-linking was performed by treatment
of undifferentiated cells with ethylene glycol bissuccinimidylsuccinate (Sigma) (to
a final concentration of 1.5 mM) for 30 min at room temperature, followed by
formaldehyde (Sigma) (final concentration, 1%) for 10 min. Cross-linking was
terminated with glycine (final concentration, 20 mM). After preparation of
nuclear extracts, chromatin was sonicated for 20 min at 4°C, using a 30-s on and
30-s off protocol. Chromatin was precleared with protein A agarose beads
(blocked previously with rabbit serum) at 4°C overnight. Precleared chromatin
samples were immunoprecipitated with a rabbit polyclonal anti-Klf3 antibody
(previously described in Crossley et al. [9]) or rabbit serum as a negative control.
Immunoprecipitated chromatin samples were reverse cross-linked, purified, and
subjected to real-time RT-PCR analysis. DNA prepared from chromatin samples
served as a positive control (input). The real-time RT-PCR primers were de-
signed to amplify regions around the mouse C/ebp promoter, spaced approxi-
mately 1 kb apart: 5000, 5-CCCAGGCAGAACAAAACATAGG-3 and 5-
GGGCAGGCCATTGTTTTGTA-3; 4000, 5-TGCTTTACTTGGTGCCTC
TTTG-3 and 5-TTGGTGTCGACTCCTTCATGAA-3; 3000, 5-CGGGAG
CCTGGCATCTT-3 and 5-TTCCAGGAGCGGCTACAGA-3; 2000, 5-AG
TGTGTTCCAGCTTCCTTCAAC-3 and 5-GAGGCTGACATCCTCGCTTA
TG-3; 1000, 5-GCTCCACGCTGGGTAGCA-3 and 5-CCAGGCCAGAG
CGATAGGA-3; 1, 5-AGGAGAAGGCGGGCTCTAAG-3 and 5-ATCGA
AGGCGCCAGTAGGA-3; 1000, 5-CGGTGCGGGCAAAGC-3 and 5-CG
TACCCGGTACTCGTTGCT-3.
Statistics. All data are presented as means plus standard errors of the means
(SEM). Differences between groups were analyzed using analysis of variance
(Statview Statistical Analysis Software, version 4.57). Values of P of 0.05 were
considered significant.
RESULTS
Klf3/ mice possess less white adipose tissue. In order to
assess the biological role of Klf3, we carried out the targeted
disruption of the Klf3 gene as shown in Fig. 1A. The targeting
vector is designed to delete a portion of the zinc finger region
and ablate DNA-binding and Klf3 activity. Targeting was
achieved in 129 embryonic stem cells and chimeric 129/
C57BL/6 mice were generated. These were bred to C57BL/6
animals, and germ line transmission of the targeted allele was
achieved. Heterozygotes were bred together to generate ho-
mozygous animals, and tissues from these animals were ana-
lyzed to verify that no functional Klf3 protein was detectable.
No Klf3 protein could be detected by Western blotting, and the
more sensitive EMSAs confirmed that no functional Klf3 was
present in knockout tissues (Fig. 1C). The targeting construct
used to disrupt the Klf3 gene contained the neo cassette, which
was retained in the knockout animals. To confirm that there
were no changes in expression of genes surrounding the neo
cassette (Fig. 1B), real-time RT-PCR was performed on RNA-
extracted Klf3 null and wild-type MEFs. No significant alter-
ations in expression were observed in the four genes directly
surrounding the site of neo insertion (data not shown).
To avoid variations that might arise from the mixed genetic
background, mice were back-crossed to the FVB/NJ strain for
10 generations. The population was monitored for viability.
Examination of the genotypes at 3 weeks of age revealed that
the proportion of knockouts is less than expected from Men-
delian ratios. Klf3/ mice from heterozygous crosses make up
only 17% (rather than 25%) of the total offspring at weaning
(n  353; P  0.005) (data not shown). When genotype ratios
were measured in utero at E14.5, the fraction of Klf3/ mice
was within Mendelian expectations (n  49) (data not shown).
To date there are no obvious defects to explain the reduction
in viability of the knockout after E14.5.
At birth, the Klf3/ mice appear virtually indistinguishable
from their wild-type and heterozygous littermates. However,
by the time of weaning, the Klf3/ mice are visibly smaller
than their wild-type counterparts (see Fig. S1A in the supple-
mental material). To further define this phenotype, body
weight was measured weekly from 3 to 12 weeks of age (see
Fig. S1B in the supplemental material). At each time point the
Klf3/ mice were significantly smaller than both their wild-
type and heterozygous counterparts (P  0.0001). The size
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reductions were observed in both male and female Klf3 knock-
out mice.
Klf3/ mice also appeared leaner than their wild-type and
heterozygous littermates (see Fig. S1A in the supplemental
material). We hypothesized that perhaps the reduced size of
Klf3/ mice could be partially attributed to a deficiency in
white adipose tissue, reminiscent of the impaired adipogenesis
in Klf5/ mice (21). To investigate this, the sizes of gonadal
(ovarian in females and epididymal in males) and retroperito-
neal white adipose tissue depots were compared between wild-
type, heterozygous, and Klf3/ mice at 12 weeks of age. Mac-
roscopic analyses demonstrated that, indeed, the Klf3/ mice
had dramatic reductions in the size of their fat pads compared
to wild-type mice (Fig. 2A and B). These decreases were ob-
served in both males and females. In contrast to white adipose
tissue depots, other tissues such as brown adipose tissue and
liver exhibited no gross abnormalities in morphology or size
relative to other organs (Fig. 2B). Multiple organs from wild-
type, heterozygous, and Klf3/ mice were weighed and nor-
malized for body weight (Fig. 2C). Compared with tissues from
wild-type mice, the gonadal and retroperitoneal fat pads were
reduced to 38% and 15% of normal size, respectively, in
Klf3/ males (P  0.001). Similar reductions were found in
Klf3/ females (P  0.05) (data not shown). Other tissues
including heart, lung, thymus, stomach, and spleen were equiv-
alent in mice of different genotypes although there was a slight
but detectable decrease in the size of the liver, and small
increases in kidney and brain size were observed in knockouts
for both sexes (P  0.05).
To further pinpoint the stage of development at which the
reduction in white adipose tissue is first evident, neonates were
studied. Transverse sections of 4-day-old wild-type, heterozy-
gous, and Klf3/ neonates were taken and stained with (H-E).
Sections were taken at three different levels through the mouse
body at the levels of the neck and scapula (Fig. 2E). Klf3/
neonates had reduced subcutaneous white adipose tissue (Fig.
2D and E, the unstained band underlying the skin) compared
to wild-type and heterozygous neonates. Again, it appears that
the amount of brown adipose tissue is similar among all geno-
types (Fig. 2E, arrows in the lower panel), suggesting that there
is a particular deficiency in white adipose tissue, in addition to
the general reduction in size that is detectable even at this early
stage of development.
Fat pads in Klf3/ mice have smaller and fewer cells. To
characterize the apparent white adipose tissue deficiency at the
cellular level, we investigated whether Klf3/ mice had less fat
1 kb
FIG. 1. Targeted disruption of Klf3 in mice. (A) Generation of Klf3 knockout mice. Schematic representation of the wild-type (WT) Klf3 locus
(with a partial restriction map), the targeting vector, and the targeted allele. Black boxes represent exons. The zinc finger domain is contained in
the last two exons. The gray box represents the phosphoglycerate kinase (PGK)-neo cassette. Abbreviations: S, StuI; C, ClaI; Sp, SpeI; X, XhoI;
Sa, SalI; P, PmlI; Xb, XbaI. (B) Schematic showing genomic location of murine Klf3 and neighboring genes on chromosome 5. Pgm2, glucose
phosphomutase 2; Tbc1d1, TBC1 domain family, member 1; Tlr1, Toll-like receptor 1; and Tlr6, Toll-like receptor 6. (C) Western blotting (left
panel) using anti-Klf3 serum, showing full-length Klf3 ectopically expressed in COS cells (lane 1), COS cells alone (lane 2), and spleen samples
from Klf3 knockout and heterozygous littermates (lanes 3 and 4, respectively). The right panels (lanes 5 to 18) show EMSAs using the -major
globin gene promoter 90 CACCC box. The bands generated by Klf3, Sp1, and Sp3 are indicated by arrows and are supershifted by appropriate
antisera.
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FIG. 2. Klf3/ mice have reduced fat mass compared to wild-type mice. (A) Peritoneal cavity of wild-type and Klf3/ mice showing ovarian (black
arrows) and retroperitoneal (blue arrows) white adipose tissue (WAT). (B) Organs were dissected from 12-week-old mice. A reduction in size was seen
in Klf3/ white adipose tissue samples, while the gross morphology of the brown adipose tissue (BAT) and liver appeared similar between genotypes.
(C) Relative weights of various organs. Values are plotted as a percentage of body weight at 12 weeks of age. The results are expressed as means plus
SEM from nine wild-type, five Klf3/, and eight Klf3/ male mice. *, P  0.001 for Klf3
/ versus wild-type/Klf3 / mice. epi, epididymal; RP,
retroperitoneal. (D and E) Reduced subcutaneous white adipose tissue in Klf3/ neonates. Transverse sections were taken from the neck and scapula
of wild-type, heterozygous, and Klf3/ mice at 4 days of age (n  3 for each genotype). Images in panel D are at a magnification of 40. Panel E shows
sequential sections taken at the upper, middle, and lower torso at a magnification of 8 (n  3 for each genotype). The unstained rings underlying the skin
represent areas of subcutaneous white adipose tissue. Brown adipose tissue is indicated by arrows in the lower panel. Sections were stained with H-E.
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because the size of the individual cells was reduced and/or
because there were fewer cells present in fat pads. Histological
sections of white adipose tissue stained with H-E suggest that
the cells from Klf3/ mice are smaller in diameter than wild-
type cells (Fig. 3A). To confirm this result, cells were isolated
by collagenase digestion, and their diameters were measured.
It was confirmed that in Klf3/ animals there was a distinct
shift toward cells of a smaller diameter (Fig. 3B).
FIG. 3. White adipose tissue from Klf3/ mice has smaller and fewer adipocytes. (A) Histological sections of epididymal white adipose tissue
were stained with H-E. (B) Size distribution of adipocytes isolated from the epididymal white adipose tissue of wild-type, Klf3/, and Klf3/ mice.
Adipocytes were isolated by collagenase digestion and fixed with osmium tetroxide (n 3 for each genotype). Adipocyte diameter was determined
for 885 wild-type, 1,037 Klf3 /, and 1,506 Klf3/ adipocytes using Photoshop software. (C) DNA content was used as a measure of cell number.
Results are expressed as means plus SEM of five animals per genotype. , P 0.001 for Klf3/ versus wild-type/Klf3/ mice. WAT, white adipose
tissue.
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To determine how much smaller the Klf3/ cells were com-
pared to wild type, the measured diameter of each cell was
used to estimate cell volume (assuming cells are spherical). On
average, the Klf3/ cells were 61% of the size of wild-type
cells (see Fig. S2 in the supplemental material). This reduction
in size is not sufficient to explain the total deficit of white
adipose tissue, as the mice were observed to have 38% (rather
than 61%) of the amount of gonadal white adipose tissue
observed in wild-type littermates (Fig. 2C) (note that the size
measurements were carried out only in male mice). We there-
fore sought to investigate if the fat pads also contained fewer
cells.
We used the DNA content of epididymal fat pads to provide
an estimate of the number of cells in the fat pads. Compared
to wild-type samples, epididymal pads from Klf3/ mice have
only 56% of the amount of total DNA content (P  0.001)
(Fig. 3C), suggesting that there are approximately 56% of the
number of cells in the tissue. This number is obviously an
estimate that relies on the assumption that the proportion of
diploid cells is equivalent in the two samples. But, importantly,
when this reduction (0.56) is combined with the smaller size of
the cells (0.61), the result (0.56  0.61  0.34) approximates
the total amount of gonadal white adipose tissue observed, i.e.,
38% (Fig. 2C). This suggests that the reduction in the size and
number of cells in the fat of Klf3 null mice can account for the
observed deficit in white adipose tissue.
MEFs from Klf3/ animals display enhanced adipocyte
differentiation. In vivo many processes directly or indirectly
influence fat accumulation. Thus, the reduction in white adi-
pose tissue observed in the Klf3 null neonates and in the
12-week-old animals could be due to a combination of factors.
One possibility is that the reduction in white adipose tissue is
due to alterations in cellular proliferation rates in Klf3 null
animals. To address this hypothesis, proliferation rates of Klf3
null and wild-type MEFs were assayed by both fluorescence-
activated cell sorting cell cycle analysis and the CellTiter 96
assay (Promega). No differences in cell cycle or proliferation
were observed (data not shown). To investigate whether the
reduction in adipose tissue could be due to a specific alteration
in adipocyte differentiation, in vitro cell culture experiments
were carried out. MEFs were derived from E14.5 Klf3 null and
wild-type embryos and exposed to inducers of adipocyte dif-
ferentiation. The cells were then stained and counterstained
with Oil Red O and hematoxylin, respectively, at day 8 after
hormonal induction. A proportion of these fibroblasts acquired
characteristics of adipocytes, as assessed by the cytoplasmic
accumulation of lipid droplets. In three independent experi-
ments, Klf3 null MEFs displayed an enhanced ability to accu-
mulate lipid compared to wild-type cells in culture (Fig. 4).
Klf3 levels decrease upon adipocyte differentiation of
3T3-L1 cells in culture. To further define the function of Klf3
in adipogenesis, we switched to the 3T3-L1 cell system. 3T3-L1
cells can be induced to differentiate in culture. Several gene
regulatory proteins of the KLF family, such as Klf2, Klf5, and
Klf15, which have been shown to play important roles in the
differentiation of adipocytes, are dynamically regulated during
3T3-L1 differentiation (2, 19, 21) (Fig. 5A). We monitored Klf3
expression during the differentiation of 3T3-L1 cells. Total
RNA was collected at various stages throughout 3T3-L1 dif-
ferentiation and analyzed by real-time RT-PCR. Klf3 mRNA
was expressed most highly at day 0 in 3T3-L1 preadipocytes
and diminished upon adipocyte differentiation (Fig. 5A). As
expected, other factors such as C/ebp, C/ebp, C/ebp, Ppar,
and aP2 were induced with 3T3-L1 differentiation, whereas
Klf2 declined (Fig. 5A and data not shown). To determine if
the decline in Klf3 mRNA was also reflected in protein levels
and DNA-binding activity, Western blotting and EMSAs were
carried out. These experiments confirmed that Klf3 mRNA,
protein, and DNA-binding activity all decline during the dif-
ferentiation of 3T3-L1 cells (Fig. 5B, C).
Overexpression of Klf3 inhibits adipocytic differentiation of
3T3-L1 cells in vitro. The dynamic regulation of Klf3 suggested
that it may be a direct regulator of adipocyte differentiation.
To test whether Klf3 shutdown was critical to proper adipocyte
differentiation, we used a retroviral system to enforce the ec-
topic overexpression of Klf3 and monitored the effect on adi-
pocyte differentiation. As judged by Oil Red O staining, forced
expression of Klf3 significantly inhibited lipid accumulation
(Fig. 6A). The forced expression of Klf3 had no appreciable
effect on cell viability or number (data not shown).
Klf3 represses transcription by recruiting the corepressor
protein CtBP through a PXDLS motif in its repression domain
(32). In order to determine whether this interaction is required
for inhibiting adipocyte differentiation, a Klf3 mutant that is
unable to bind CtBP was tested. This mutant (Klf3
DL) car-
ries a point mutation in the PXDLS motif of Klf3 but is oth-
erwise intact (32). Forced overexpression of the mutant
Klf3
DL had no effect on differentiation (Fig. 6A). Figure 6B
confirms that both the Klf3 and Klf3
DL proteins were de-
tectably overexpressed. Together, these data indicate that Klf3
plays a role in adipocyte differentiation and that this role re-
quires the recruitment of CtBP.
FIG. 4. Enhanced adipocyte differentiation in Klf3-deficient cells.
Fibroblasts derived from E14.5 wild-type (/) and Klf3 knockout
(/) mouse embryos were induced to undergo adipocyte differenti-
ation. Cells were stained with Oil Red O and counterstained with
hematoxylin on day 8. Images are representative of at least three
independent experiments.
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FIG. 5. Klf3 expression during 3T3-L1 adipocyte differentiation. (A) Total RNA was extracted from 3T3-L1 cells at the indicated times before
and after induction of differentiation. The expression levels of Klf3, Klf2, Klf15, and C/ebp were determined by quantitative real-time RT-PCR
and normalized to 18S rRNA levels. These levels were then further normalized with respect to the level in 3T3-L1 cells at day 0, set at 1. Results
are expressed as means plus SEM (n  3). (B and C) Nuclear extracts were made from cells at day 0 (preadipocytes) and day 10 (adipocytes) of
3T3-L1 differentiation. An EMSA using a double-stranded oligonucleotide probe containing a CACCC sequence shows that Klf3 is present in
preadipocytes and reduced in adipocytes (B). Anti-Klf3 antibody supershift reactions confirm that these species are Klf3 (lanes 2 and 4). Note that
supershift of the Klf3 band reveals the presence of another CACCC box binding protein that runs similarly to Klf3. All data are representative of
at least three independent experiments. Klf3 protein was detected by Western blot analysis using an anti-Klf3 antibody (C). -Actin was used as
a loading control. Duplicates are shown for each condition. All data are representative of at least three independent experiments.
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Derepression of C/ebp in the absence of Klf3. We hypoth-
esized that Klf3 and its corepressor CtBP may be exerting an
effect on adipogenesis by repressing a gene that is important in
adipocyte differentiation. Several observations suggested
C/ebp as a possible candidate. First, C/ebp has been re-
ported as a gene repressed by CtBP (11). Second, defects in
C/ebp generate a phenotype reminiscent of the Klf3 knockout
phenotype, that is, reduction in white adipose tissue but nor-
mal brown adipose tissue (18). It has been shown that the
C/ebp gene promoter is bound and regulated by the KLF-
related protein Sp1 (30), suggesting that the C/ebp gene pro-
moter contains functional CACCC boxes through which Klf3
may also operate. Finally, the C/ebp expression pattern dur-
ing 3T3-L1 differentiation is consistent with repression by Klf3
(Fig. 5A); i.e., C/ebp is low when Klf3 levels are high and vice
versa. We therefore investigated whether Klf3 represses
C/ebp.
We first compared C/ebp mRNA levels in normal and Klf3
knockout undifferentiated MEFs. As shown in Fig. 7A, C/ebp
is derepressed in Klf3 knockout cells. We also examined CtBP-
deficient MEFs to confirm the previous microarray experi-
ments that indicated that C/ebp levels are elevated in these
cells (11). Real-time RT-PCR analysis confirmed that C/ebp
levels were approximately fourfold higher in the absence of
CtBP (Fig. 7B). Finally, we examined RNA from the white ad-
ipose tissue of Klf3/ mice and their wild-type counterparts. We
again observed two to three times the amount of C/ebp in Klf3
null white adipose tissue compared to wild-type white adipose
tissue (Fig. 7A). Taken together, these results indicate that
C/ebp is consistently found to be derepressed in the absence of
Klf3 or its corepressor CtBP. We also examined the expression of
other adipogenic genes in white adipose tissue. Real-time RT-
PCR analysis indicated an approximately twofold increase in lev-
els of Ppar, C/ebp, and Klf15 in Klf3 null white adipose tissue
(Fig. 7C). We did not observe any significant alteration in the
expression of C/ebp	, Klf2, or Klf5. These findings suggest that
Klf3 acts as a regulator of adipocyte differentiation at least in part
through repressing C/ebp expression.
FIG. 6. Reduced adipocyte differentiation in 3T3-L1 cells stably expressing Klf3. (A) 3T3-L1 preadipocytes were retrovirally infected with
empty vector (EV), Klf3, or Klf3
DL and subjected to Oil Red O staining to assess for lipid accumulation at day 5 of differentiation. Macroscopic
(upper panel) and microscopic (magnification, 100; lower panel) views are shown. Images are representative of at least three independent
experiments. (B) 3T3-L1 cells were retrovirally infected with EV, Klf3, or Klf3
DL and differentiated. Nuclear extracts were prepared and
subjected to Western blot analysis using the indicated antibodies. All data are representative of at least three independent experiments.
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Klf3 binds the endogenous C/ebp promoter in 3T3-L1 cells.
To determine whether Klf3 directly binds the C/ebp promoter
in vivo to mediate repression, we performed ChIP assays. ChIP
material was obtained from 3T3-L1 preadipocytes, in which
Klf3 is abundant, and was immunoprecipitated with an anti-
Klf3 antibody. A primer walk across the C/ebp gene was
conducted to compare the amounts of Klf3 at the C/ebp
promoter and at regions up- and downstream. Klf3 occupancy
was seen most strongly at the region around the transcriptional
start site (Fig. 8). This region contains multiple CACCC boxes
matching the Klf3 binding site consensus (data not shown).
There was minimal Klf3 binding detected in regions other than
the C/ebp promoter. In addition to the negative control re-
gions of DNA upstream and downstream of the promoter,
immunoprecipitation with a nonimmune serum control
showed no significant enrichment at the C/ebp promoter.
Taken together, these results suggest that Klf3 directly associ-
ates with the C/ebp promoter and contributes to its repression
in vivo.
DISCUSSION
The molecular pathways that regulate adipogenesis have
been extensively studied. PPAR and C/EBP family transcrip-
tion factors have been shown to play a dominant role, partic-
ularly in driving the terminal differentiation and maturation of
adipocytes (22, 28). More recently, KLF proteins have been
shown to regulate both the early (2, 21) and, in the case of
Klf15 (19), also the later stages of adipogenesis. The KLFs
have been shown to act, at least in part, by regulating the
expression of PPAR. Klf2 inhibits expression of the PPAR
gene (2), while Klf5 and Klf15 drive it (19, 21). Similarly, the
KLF-related proteins Sp1 and Sp3 have been implicated in
regulating C/ebp expression (12, 30).
Our results indicate that a repressive KLF, Klf3, is also
involved in the control of adipogenesis. Its abundance in un-
induced 3T3-L1 cells and its shutdown as adipogenesis pro-
ceeds suggest that it may play an early role in inhibiting adi-
pogenesis. As Klf3 expression diminishes, C/ebp expression
concomitantly increases. Forced overexpression of Klf3 in the
3T3-L1 system blocks adipogenesis, but a mutant form of Klf3
that cannot bind the corepressor CtBP is ineffective. This result
implicates CtBP in the control of adipogenesis.
There is now significant evidence linking CtBP with meta-
bolic control and adipogenesis. CtBP responds to NADH lev-
els, and one proposal is that it dimerizes (or multimerizes) in
the presence of NADH and that its conformation is altered so
that it is able to bind to Pro-X-Asp-Leu-Ser motifs found in its
partner transcriptional repressors (1, 15, 31, 37). Thus, CtBP is
viewed as a metabolic sensor that can modulate gene expres-
sion in response to the redox state of the cell. Studies in CtBP
null MEFs have indicated that it represses several genes in-
volved in metabolism and the regulation of lipids, including
lactate dehydrogenase 2 (B chain), glyceraldehyde-3-phos-
phate dehydrogenase, glucose phosphate isomerase, lipopro-
tein lipase 1, and the elongation of long chain fatty acids genes
(Elo2 and Elo3) (11). Furthermore CtBP has recently been
FIG. 7. C/ebp is derepressed in the absence of Klf3 and CtBP.
Quantitative real-time RT-PCR analysis of wild-type (/) and
Klf3 / white adipose tissue and MEFs (A), CtBP/ and CtBP/
MEFs (B), and wild-type and Klf3/ white adipose tissue (C). Ex-
pression levels were normalized to the level of 18S rRNA. These levels
were then further normalized with respect to the level in wild-type
sample or CtBP/ MEFs, set at 1. Error bars indicate SEM. P values
are defined as follows, and significant differences are indicated by
asterisks: 0.05 for Klf3/ versus wild-type (A; n  4 for each geno-
type), 0.05 for CtBP/ versus CtBP/ (B; n  3 for each geno-
type), and 0.05 for Klf3/ versus wild-type (C; n  3 for each
genotype).
FIG. 8. Klf3 binds at to the C/ebp promoter. 3T3-L1 preadipo-
cytes were fixed and chromatin material was subjected to ChIP anal-
ysis. Chromatin was immunoprecipitated using an anti-Klf3 antibody
or rabbit serum as a negative control. Primers used for real-time
RT-PCR were targeted to various regions spaced 1 kb apart along the
C/ebp promoter.
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found to regulate lipid droplet accumulation in fibroblasts (3).
Further evidence linking CtBP to adipogenesis comes from the
observation that CtBP binds RIP140 (34), a nuclear hormone
receptor that regulates fat accumulation (7, 16). Interestingly,
Sir2, another corepressor protein that responds to changes in
NAD/NADH ratios, has also been implicated in adipogene-
sis. In contrast to CtBP, Sir2 is active when NAD (rather than
NADH) levels are high. Upon food withdrawal, Sir2 represses
PPAR expression (26). Thus, it appears that both Sir2 and
CtBP may regulate adipogenesis in response to NAD/NADH
ratios.
Our results indicate that Klf3 and CtBP repress the C/ebp
promoter. This is consistent with the fact that functional
CACCC boxes have been identified in the C/ebp promoter
(30) and that C/ebp has previously been listed as a gene that
is derepressed in Ctbp knockout cells (11). The phenotype of
the Klf3 knockout is also consistent with a defect in C/ebp
expression. That is, C/ebp has been shown to be important for
white but not brown adipose tissue (18), and we observed a
deficiency in white but not brown adipose tissue in the Klf3
knockout. We also sought to use ChIP assays to test for the
presence of CtBP at the C/ebp promoter. Although we ob-
served some enrichment around the start of transcription, high
background levels with existing CtBP antiserum hindered in-
terpretation of these experiments (data not shown), so we have
not yet directly shown that CtBP is present. Nevertheless, the
observations that the Klf3 mutant unable to bind CtBP is
unable to block adipogenesis in 3T3-L1 cells and that C/ebp is
derepressed in CtBP null MEFs support for a role for CtBP in
the process.
On the other hand, while our results suggest that derepres-
sion of C/ebp interferes with normal adipogenesis and con-
tributes to the Klf3 phenotype, this derepression alone may not
fully explain the mouse phenotype and cellular results. For
instance, it is unexpected that the Klf3 knockout mouse has less
fat, whereas in culture Klf3 appears to have an inhibitory role
and Klf3 knockout fibroblasts differentiate into adipocytes
more readily than normal fibroblasts. We propose two possible
explanations. C/EBP is known to be antimitotic (33); thus, it
is possible that in culture in vitro its derepression and prema-
ture accumulation result in an increase in lipid-accumulating
cells, but in mice in vivo the premature expression of this
antimitotic factor prevents expansion of adipocyte progenitors
and results in a smaller fat pad. It is also likely that indirect
processes influence fat pad size in vivo. Klf3 is broadly ex-
pressed, and there may be subtle defects in many tissues that
affect physiology and/or behavior. Results from a preliminary
feeding study suggest that the knockouts may feed less (data
not shown), so this could well partly explain the phenotype in
vivo. Although there are likely to be multiple factors influenc-
ing the ultimate in vivo phenotype, the results from 3T3-L1
cells, taken together with the altered adipogenesis in Klf3
knockout fibroblasts in culture, suggest that Klf3 does play a
direct role in adipogenesis and that derepression of C/ebp is
one contribution to the phenotype observed in the mice.
Precisely how Klf3 fits within the hierarchy of KLFs that
control adipogenesis remains to be defined. The Klf3 gene is
driven by Klf1 in erythroid cells (10) and by Klf4 in skin cells
(23). During 3T3-L1 differentiation the decline in Klf3 levels
coincides with the decline in Klf2 (Lklf), suggesting the possi-
bility that Klf3 is driven by Klf2 during adipogenesis. Klf1,
Klf2, and Klf4 form a closely related cluster of activating KLFs
within the KLF family, and it is possible that they regulate
similar sets of genes, including Klf3, in different tissues. Future
experiments will explore the interplay between different KLFs
in different tissues during development.
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